Dieter Weinand ’87 was appointed as the Chair of the Board of Directors at Umoja Biopharma, Inc., an immuno-oncology company that develops therapeutics to reprogram immune cells to treat cancer patients. Weinand is the former CEO of Bayer Pharma AG and has over 25 years of experience in the pharmaceutical industry.
